29 studies found for:    TRICHOHEPATOENTERIC SYNDROME 1
Show Display Options
Rank Status Study
1 Completed The 1 Year Follow-up Objective Oral Appliance Compliance
Condition: Sleep-disordered Breathing
Intervention: Device: Mandibular Advancement Device
2 Recruiting Development of a MID for the 1-minute Sit-to-stand Test
Condition: COPD
Intervention: Procedure: Pulmonary rehabilitation
3 Recruiting Detection of ASD at the 1st Birthday as Standard of Care: The Get SET Early Model
Condition: Autism Spectrum Disorder
Intervention:
4 Recruiting Predicting Pathological Response Within the 1st Week of Chemotherapy Using Diffuse Optical Spectroscopic Imaging
Condition: Breast Cancer
Intervention: Device: Diffuse Optical Spectroscopy Imaging
5 Not yet recruiting Combined Effect of Natural Killer Cell and Doublet Chemotherapy in Advanced NSCLC as the 1st Line Treatment
Condition: Non-small Cell Lung Cancer
Intervention: Biological: ANKL(Ex vivo-expanded NK cell enriched lymphocytes)
6 Active, not recruiting Phase II Trial to Evaluate the Efficacy and Safety of HM61713 (BI 1482694) as the 1st-line NSCLC Anticancer Therapy
Condition: Non Small Cell Lung Cancer
Intervention: Drug: HM61713 (BI 1482694)
7 Enrolling by invitation Defining the Optimal Cryoballoon Duration Therapy for Treatment of Atrial Fibrillation: Defining the Optimal Cryoballoon Duration Therapy for Treatment of Atrial Fibrillation: The 1-2-3 Study
Condition: Atrial Fibrillation
Intervention: Other: Cryoballoon ablation
8 Terminated Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma
Condition: Glioblastoma
Interventions: Drug: Cetuximab;   Drug: Cilengitide EMD 121974
9 Recruiting A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)
Condition: Breast Cancer
Interventions: Drug: Capecitabine;   Procedure: endocrine therapy
10 Active, not recruiting Validation of the 1-minute Sit-to-stand Test in Patients With COPD
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Other: 1-minute sit-to-stand test
11 Active, not recruiting Ipilimumab and Dabrafenib in the 1st Line Tx of Unresectable Stage III/IV Melanoma
Condition: Stage III or IV Melanoma
Intervention: Drug: ipilimumab and dabrafenib
12 Unknown  Down Syndrome - Comparison of Screening Methods in the 1st and 2nd Trimesters
Conditions: Down Syndrome;   Chromosome Abnormalities
Interventions: Procedure: Ultrasound;   Procedure: Serum screen
13 Enrolling by invitation The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection
Condition: Helicobacter Infection
Interventions: Drug: 10 day sequential therapy (Esomeprazole, amoxicillin, clarithromycin, metronidazole);   Procedure: 7 day tailored therapy based on antimicrobial susceptibility testing;   Drug: PPI based triple therapy [Esomeprazole, amoxicillin, clarithromycin];   Drug: bismuth quadruple therapy [Esomeprazole, Tri potassium dicitrate bismuthate, Metronidazole, Tetracycline];   Drug: moxifloxacin triple therapy [Esomeprazole, Moxifloxacin, Amoxicillin]
14 Completed Clinical Analysis of the Influence of Using the Skin Care Products on the Diaper Area in Comparison With Using a Cotton Wool Cloth, Moistened With Clear Water on the Skin Physiology of the Newborns From the 1st Day to the 4th Week of Life
Condition: Postnatal Skin Physiology
Intervention:
15 Active, not recruiting A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type Patients
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Cetuximab + Oxaliplatin + 5FU/FA;   Drug: Oxaliplatin + 5FU/FA
16 Completed
Has Results
Azilsartan Circadian and Sleep Pressure
Condition: Hypertension
Interventions: Drug: Azilsartan;   Drug: Amlodipine
17 Completed A Trial of Meal Replacement at a Community Diabetes Clinic Serving a Low Socioeconomic Hispanic Population
Conditions: Type 2 Diabetes;   Obesity
Interventions: Other: Meal Replacement;   Other: Standard Care
18 Completed Salt Iodization: Meeting the Needs of Pregnancy, Lactation and Infancy
Condition: Iodine Deficiency
Intervention:
19 Completed Effect of Adductor-Canal-Blockade on High Pain Responders After Total Knee Arthroplasty
Condition: Pain After Total Knee Arthroplasty
Interventions: Drug: Ropivacaine;   Drug: Saline
20 Withdrawn Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF)
Condition: Idiopathic Short Stature
Intervention: Drug: Nutropin [Somatropin (rDNA origin) for injection]

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Indicates status has not been verified in more than two years